US Stock MarketDetailed Quotes

NMTRQ 9 METERS BIOPHARMA INC

Watchlist

0.000
0.0000.00%

15min DelayClose Nov 29 13:00 ET

14.46Market Cap0.00P/E (TTM)

9 METERS BIOPHARMA INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-0.01%-9.75M

-26.34%-37.24M

-22.18%-9.74M

-21.97%-9.97M

-9.53%-7.79M

-56.60%-9.75M

-51.87%-29.48M

-24.18%-7.97M

-96.42%-8.17M

-14.70%-7.11M

Net income from continuing operations

-22.17%-13.87M

-19.00%-43.77M

-24.86%-11.93M

30.91%-9.35M

-34.86%-11.13M

-109.01%-11.35M

40.19%-36.78M

-92.54%-9.55M

-62.48%-13.54M

81.49%-8.25M

Operating gains losses

--492.93K

-5,847.93%-416.36K

---339.36K

----

-100.18%-7K

--0

Depreciation and amortization

-18.32%1.33K

12.54%8.52K

-12.89%2.54K

18.33%1.57K

25.48%2.79K

46.58%1.63K

-59.04%7.57K

81.34%2.92K

-81.42%1.33K

-50.21%2.22K

Other non cash items

--578.9K

-12.17%2.33M

--1.33M

-80.83%500.35K

----

-91.90%2.65M

--0

18.79%2.61M

--0

Change In working capital

153.20%2.31M

-70.38%661.42K

-56.97%452.85K

-179.40%-1.77M

420.31%1.07M

172.71%911.78K

187.94%2.23M

155.69%1.05M

20.43%2.23M

138.09%205.07K

-Change in prepaid assets

55.57%1.78M

81.49%-368.67K

-529.89%-767.98K

40.94%-700.32K

88.68%-46.81K

524.70%1.15M

-346.96%-1.99M

-328.59%-121.92K

-16,237.70%-1.19M

27.81%-413.7K

-Change in payables and accrued expense

323.78%525.13K

-75.62%1.03M

3.96%1.22M

-131.33%-1.07M

80.00%1.11M

76.15%-234.67K

245.97%4.22M

160.44%1.17M

85.22%3.42M

1,681.34%618.77K

Cash from discontinued investing activities

Operating cash flow

-0.01%-9.75M

-26.34%-37.24M

-22.18%-9.74M

-21.97%-9.97M

-9.53%-7.79M

-56.60%-9.75M

-51.87%-29.48M

-24.18%-7.97M

-96.42%-8.17M

-14.70%-7.11M

Investing cash flow

Cash flow from continuing investing activities

99.88%-2.84K

43.30%-2.84K

23.73%-2.43M

-2.63K

-2.42M

99.94%-1.88K

Net PPE purchase and sale

--0

77.22%-2.84K

--0

43.30%-2.84K

-390.60%-12.48K

---2.63K

---2.96K

26.07%-1.88K

Net intangibles purchase and sale

----

--0

----

21.71%-2.49M

--0

----

Net other investing changes

----

--75K

--0

----

Cash from discontinued investing activities

Investing cash flow

--0

99.88%-2.84K

--0

43.30%-2.84K

23.73%-2.43M

---2.63K

---2.42M

99.94%-1.88K

Financing cash flow

Cash flow from continuing financing activities

-12.29M

-51.49%19.91M

10,960.15%19.91M

-26.50%41.05M

-95.73%1.36M

-94.24%180.03K

61.65%32.64M

Net issuance payments of debt

---16.75M

36,183.09%21M

--0

--21M

--0

-251.06%-58.2K

--0

Net common stock issuance

--5M

--0

-7.13%34.5M

--0

----

Proceeds from stock option exercised by employees

----

--0

----

276.10%9.51M

181.36%1.36M

-48.00%430.03K

-35.26%789.18K

Net other financing activities

---537.68K

62.49%-1.09M

--0

----

54.82%-2.9M

--0

-241.77%-250K

----

Cash from discontinued financing activities

Financing cash flow

---12.29M

-51.49%19.91M

--0

10,960.15%19.91M

--0

-26.50%41.05M

-95.73%1.36M

-94.24%180.03K

61.65%32.64M

Net cash flow

Beginning cash position

-36.89%29.66M

24.15%46.99M

-26.51%39.4M

-53.99%29.46M

-3.26%37.24M

24.15%46.99M

724.12%37.85M

331.08%53.61M

375.18%64.02M

1,343.02%38.5M

Current changes in cash

-125.98%-22.04M

-289.61%-17.33M

-47.21%-9.74M

195.46%9.94M

-130.50%-7.79M

-1,612.47%-9.75M

-72.51%9.14M

-126.03%-6.62M

-903.86%-10.41M

136.24%25.53M

End cash Position

-79.53%7.62M

-36.89%29.66M

-26.51%39.4M

-53.99%29.46M

-3.26%37.24M

24.15%46.99M

331.08%53.61M

375.18%64.02M

Free cash flow

0.02%-9.75M

-16.45%-37.25M

-22.14%-9.74M

6.56%-9.97M

-9.50%-7.79M

-56.52%-9.75M

-41.54%-31.98M

-24.22%-7.97M

-156.41%-10.67M

24.23%-7.11M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-0.01%-9.75M	-26.34%-37.24M	-22.18%-9.74M	-21.97%-9.97M	-9.53%-7.79M	-56.60%-9.75M	-51.87%-29.48M	-24.18%-7.97M	-96.42%-8.17M	-14.70%-7.11M
Net income from continuing operations	-22.17%-13.87M	-19.00%-43.77M	-24.86%-11.93M	30.91%-9.35M	-34.86%-11.13M	-109.01%-11.35M	40.19%-36.78M	-92.54%-9.55M	-62.48%-13.54M	81.49%-8.25M
Operating gains losses	--492.93K	-5,847.93%-416.36K	---339.36K	----	----	----	-100.18%-7K	--0	--0	--0
Depreciation and amortization	-18.32%1.33K	12.54%8.52K	-12.89%2.54K	18.33%1.57K	25.48%2.79K	46.58%1.63K	-59.04%7.57K	81.34%2.92K	-81.42%1.33K	-50.21%2.22K
Other non cash items	--578.9K	-12.17%2.33M	--1.33M	-80.83%500.35K	----	----	-91.90%2.65M	--0	18.79%2.61M	--0
Change In working capital	153.20%2.31M	-70.38%661.42K	-56.97%452.85K	-179.40%-1.77M	420.31%1.07M	172.71%911.78K	187.94%2.23M	155.69%1.05M	20.43%2.23M	138.09%205.07K
-Change in prepaid assets	55.57%1.78M	81.49%-368.67K	-529.89%-767.98K	40.94%-700.32K	88.68%-46.81K	524.70%1.15M	-346.96%-1.99M	-328.59%-121.92K	-16,237.70%-1.19M	27.81%-413.7K
-Change in payables and accrued expense	323.78%525.13K	-75.62%1.03M	3.96%1.22M	-131.33%-1.07M	80.00%1.11M	76.15%-234.67K	245.97%4.22M	160.44%1.17M	85.22%3.42M	1,681.34%618.77K
Cash from discontinued investing activities
Operating cash flow	-0.01%-9.75M	-26.34%-37.24M	-22.18%-9.74M	-21.97%-9.97M	-9.53%-7.79M	-56.60%-9.75M	-51.87%-29.48M	-24.18%-7.97M	-96.42%-8.17M	-14.70%-7.11M
Investing cash flow
Cash flow from continuing investing activities	0	99.88%-2.84K	0	0	0	43.30%-2.84K	23.73%-2.43M	-2.63K	-2.42M	99.94%-1.88K
Net PPE purchase and sale	--0	77.22%-2.84K	--0	--0	--0	43.30%-2.84K	-390.60%-12.48K	---2.63K	---2.96K	26.07%-1.88K
Net intangibles purchase and sale	----	--0	--0	----	----	----	21.71%-2.49M	--0	----	----
Net other investing changes	----	----	----	----	----	----	--75K	--0	----	----
Cash from discontinued investing activities
Investing cash flow	--0	99.88%-2.84K	--0	--0	--0	43.30%-2.84K	23.73%-2.43M	---2.63K	---2.42M	99.94%-1.88K
Financing cash flow
Cash flow from continuing financing activities	-12.29M	-51.49%19.91M	0	10,960.15%19.91M	0	0	-26.50%41.05M	-95.73%1.36M	-94.24%180.03K	61.65%32.64M
Net issuance payments of debt	---16.75M	36,183.09%21M	--0	--21M	--0	--0	-251.06%-58.2K	--0	--0	--0
Net common stock issuance	--5M	--0	--0	--0	--0	--0	-7.13%34.5M	--0	--0	----
Proceeds from stock option exercised by employees	----	--0	--0	--0	----	----	276.10%9.51M	181.36%1.36M	-48.00%430.03K	-35.26%789.18K
Net other financing activities	---537.68K	62.49%-1.09M	--0	----	----	----	54.82%-2.9M	--0	-241.77%-250K	----
Cash from discontinued financing activities
Financing cash flow	---12.29M	-51.49%19.91M	--0	10,960.15%19.91M	--0	--0	-26.50%41.05M	-95.73%1.36M	-94.24%180.03K	61.65%32.64M
Net cash flow
Beginning cash position	-36.89%29.66M	24.15%46.99M	-26.51%39.4M	-53.99%29.46M	-3.26%37.24M	24.15%46.99M	724.12%37.85M	331.08%53.61M	375.18%64.02M	1,343.02%38.5M
Current changes in cash	-125.98%-22.04M	-289.61%-17.33M	-47.21%-9.74M	195.46%9.94M	-130.50%-7.79M	-1,612.47%-9.75M	-72.51%9.14M	-126.03%-6.62M	-903.86%-10.41M	136.24%25.53M
End cash Position	-79.53%7.62M	-36.89%29.66M	-36.89%29.66M	-26.51%39.4M	-53.99%29.46M	-3.26%37.24M	24.15%46.99M	24.15%46.99M	331.08%53.61M	375.18%64.02M
Free cash flow	0.02%-9.75M	-16.45%-37.25M	-22.14%-9.74M	6.56%-9.97M	-9.50%-7.79M	-56.52%-9.75M	-41.54%-31.98M	-24.22%-7.97M	-156.41%-10.67M	24.23%-7.11M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data